Arena Pharmaceuticals, Inc.
METHODS FOR THE TREATMENT OF SCLERODERMA
Last updated:
Abstract:
The present invention relates to, inter alia, methods of treatment with (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydroc- yclopenta[b]indol-3-yl)acetic acid (Compound 1) for scleroderma in an individual in need thereof. ##STR00001##
Status:
Application
Type:
Utility
Filling date:
3 Oct 2019
Issue date:
16 Dec 2021